News + Filings Transactions Holdings
|
|
Opaleye Management Inc.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
ACELYRIN, Inc.
| SLRN | Common | 4,158,638 | 4,158,638 | 86,915,534,000 | 86,915,534,000 | 20.79 | |
Hist
| 06/30/2023 |
|
Biohaven Pharmaceutical Holding Co Ltd.
| BHVN | COM | 540,000 | 540,000 | 12,916,800,000 | 12,916,800,000 | 3.09 | |
Hist
| 06/30/2023 |
|
GERON CORP
| GERN | COM | 2,350,000 | 2,350,000 | 7,543,500,000 | 7,543,500,000 | 1.80 | 0.46 |
Hist
| 06/30/2023 |
|
MARINUS PHARMACEUTICALS, INC.
| MRNS | Common | 625,000 | 625,000 | 6,787,500,000 | 6,787,500,000 | 1.62 | 1.24 |
Hist
| 06/30/2023 |
|
KalVista Pharmaceuticals, Inc.
| KALV | Common | 720,000 | 720,000 | 6,480,000,000 | 6,480,000,000 | 1.55 | 2.10 |
Hist
| 06/30/2023 |
|
CymaBay Therapeutics, Inc.
| CBAY | Common | 566,700 | 566,700 | 6,205,365,000 | 6,205,365,000 | 1.48 | 0.58 |
Hist
| 06/30/2023 |
|
Theravance Biopharma, Inc.
| TBPH | COM | 543,500 | 543,500 | 5,625,225,000 | 5,625,225,000 | 1.35 | 0.94 |
Hist
| 06/30/2023 |
|
ACADIA PHARMACEUTICALS INC
| ACAD | Common | 217,000 | 217,000 | 5,197,150,000 | 5,197,150,000 | 1.24 | 0.13 |
Hist
| 06/30/2023 |
|
Intellia Therapeutics, Inc.
| NTLA | Common | 120,000 | 120,000 | 4,893,600,000 | 4,893,600,000 | 1.17 | 0.14 |
Hist
| 06/30/2023 |
|
Trevi Therapeutics, Inc.
| TRVI | Common | 1,701,500 | 1,701,500 | 4,066,585,000 | 4,066,585,000 | 0.97 | 2.83 |
Hist
| 06/30/2023 |
|
Gossamer Bio, Inc.
| GOSS | COM | 3,370,000 | 3,370,000 | 4,044,000,000 | 4,044,000,000 | 0.97 | 3.53 |
Hist
| 06/30/2023 |
|
Nyxoah SA
| NYXH | Common | 445,000 | 445,000 | 3,564,450,000 | 3,564,450,000 | 0.85 | 1.72 |
Hist
| 06/30/2023 |
|
Karyopharm Therapeutics Inc.
| KPTI | Common | 1,785,000 | 1,785,000 | 3,195,150,000 | 3,195,150,000 | 0.76 | |
Hist
| 06/30/2023 |
|
IOVANCE BIOTHERAPEUTICS, INC.
| IOVA | COM | 421,000 | 421,000 | 2,963,840,000 | 2,963,840,000 | 0.71 | 0.19 |
Hist
| 06/30/2023 |
|
SUTRO BIOPHARMA, INC.
| STRO | Common | 307,000 | 307,000 | 1,427,550,000 | 1,427,550,000 | 0.34 | 0.51 |
Hist
| 06/30/2023 |
|
Black Diamond Therapeutics, Inc.
| BDTX | Common | 275,000 | 275,000 | 1,388,750,000 | 1,388,750,000 | 0.33 | 0.75 |
Hist
| 06/30/2023 |
|
Jounce Therapeutics, Inc.
| JNCE | Common | 669,944 | 669,944 | 917,823,000 | 917,823,000 | 0.22 | 1.28 |
Hist
| 06/30/2023 |
|
Verastem, Inc.
| VSTM | Common | 102,000 | 102,000 | 758,880,000 | 758,880,000 | 0.18 | 0.05 |
Hist
| 06/30/2023 |
|
IGM Biosciences, Inc.
| IGMS | Common | 63,500 | 63,500 | 586,105,000 | 586,105,000 | 0.14 | 0.15 |
Hist
| 06/30/2023 |
|
Fulcrum Therapeutics, Inc.
| FULC | Common | 143,600 | 143,600 | 473,880,000 | 473,880,000 | 0.11 | 0.23 |
Hist
| 06/30/2023 |
|
Kezar Life Sciences, Inc.
| KZR | Common | 98,796 | 98,796 | 242,050,000 | 242,050,000 | 0.06 | 0.14 |
Hist
| 06/30/2023 |
|
|
|
|